On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper patent listings in the U.S. Food & Drug Administration’s (FDA) Orange Book.
/PRNewswire/ The renal anemia therapeutics market is estimated to grow by USD 2.08 billion during 2023-2028, growing at a CAGR of 7.59%. Akebia Therapeutics.
/PRNewswire/ The iron drugs market size is forecast to increase by USD 3,552.86 million from 2022 to 2027, at a CAGR of 9.41%, according to the recent.
/PRNewswire/ Allied Market Research published a report, titled, "Amyotrophic Lateral Sclerosis Treatment Market by Drug (Riluzole, Edaravone, and Others),.